1. MARKETS
  2. SECTOR : BANKING & FINANCE
  3. INDUSTRY : FINANCIAL CONGLOMERATES
  4. EXASCALE LABS HOLDINGS INC. - ORDINARY SHARES - CLASS A
Exascale Labs Holdings Inc. - Ordinary Shares - Class A
XNAS: XLAB
0.97-0.05(-4.90%)
19,489
XNAS Volume

XNAS 09 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Exascale Labs Holdings Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Exascale Labs Holdings Inc quarterly results: revenue, profit, and P&L – 13 quarter history

  • NEUTRAL

    Quarterly Revenue Exascale Labs Holdings Inc Jun-2026 Quarterly Revenue is $4 Million which is growth of 0% YoY.

  • NEGATIVE

    Quarterly Net Profit Exascale Labs Holdings Inc Jun-2026 Quarterly Net Profit is $-4 Million which is growth of -10149.7% YoY.

Exascale Labs Holdings Inc. - Ordinary Shares - Class A, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25
Operating Rev.
4.3
Cost Of Rev.
3.5----
Gross Profit
0.8----
⌄
-2.70.50.20.10
Operating Profit
-2-0.5-0.2-0.1-0
-2.52.82-
Profit Before Tax
-4.322.61.9-0
Tax
----
⌄
-4.322.61.9-0
Diluted NI Avail to Com Stockholders Ann.
-4.322.61.9-0
Basic EPS
-0.10.10.10.1
Diluted EPS After ExtraOrdinary
-0.10.10.1
Number Of Shares End
63.241.240.53136.9
Net Income Continuing Discontinued Operations
-4.322.61.9-0
Normalized Income
-222.61.9-0
Interest Income
-2.52.82-
Interest
-----
Net Interest Income
-2.52.82-
EBIT
-4.3-0.5-0.2-0.1-0
EBITDA
-4.2-0.5-0.2-0.1-0
Reconciled Cost Of Rev.
3.5----
Reconciled Depr.
-----
Profit From Continuing Operations
-4.322.61.9-0
Normalized EBITDA
-0.7-0.5-0.2-0.1-0
*All financials are in USD Million and price data in USD

Exascale Labs Holdings Inc competitor comparison and performance snapshot within industry

Exascale Labs Holdings Inc annual results: revenue, profit, P&L, and margins as of Jun 2026 – 11 year history

  • NEUTRAL

    Annual Revenue Exascale Labs Holdings Inc Jun-2026 Annual Revenue is $15 Million which is growth of 0% YoY.

  • NEUTRAL

    Annual Net Profit Exascale Labs Holdings Inc Jun-2026 Annual Net Profit is $-12 Million which is growth of 0% YoY.

Exascale Labs Holdings Inc. - Ordinary Shares - Class A, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphTTMJun '26Dec '25
 14.8-
Cost Of Rev. Ann.
 12.4-
Gross Profit Ann.
 2.4-
Operating Exp. Ann.
-1.9-7.2-
Operating Profit Ann.
-2.8-4.8-
 --
Other Exp. Ann.
 0-
PBT Ann.
2.3-12.2-
Tax Ann.
 -
⌄
2.3-12.2-
Diluted NI Avail to Com Stockholders Ann.
2.3-12.2-
EPS Ann.
 -0.2-
Diluted EPS Ann.
 -0.2-
Number Of Shares End
 63.240.5
Total Exp. Ann.
 --
Net Income Continuing Discontinued Operations Ann.
2.3-12.2-
Normalized Income Ann.
4.5-4.8-
Interest Income Ann.
 --
Interest Ann.
 --
EBITDA Ann.
-5.1-12.2-
Reconciled Cost Of Rev. Ann.
 12.4-
Reconciled Depr. Ann.
 --
Profit From Continuing Operations Ann.
2.3-12.2-
Normalized EBITDA Ann.
-1.5--
*All financials are in USD Million and price data in USD

Exascale Labs Holdings Inc balance sheet as of Jun 2026: assets, liabilities, reserves, and borrowings – 11 year history

  • NEUTRAL

    Total Shareholders Fund Exascale Labs Holdings Inc Jun-2026 Total Shareholders Fund is $285 Million which is growth of 0% YoY.

  • NEUTRAL

    Total Assets Exascale Labs Holdings Inc Jun-2026 Total Assets is $285 Million which is growth of 0% YoY.

Exascale Labs Holdings Inc. - Ordinary Shares - Class A, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Dec '25
285.4285.4
⌄
00
⌄
285.4285.4
Total Capitalization Ann.
285.4285.4
Tangible Assets Ann.
285.4285.4
Working Capital Ann.
-0.6
Invested Capital Ann.
-285.4
Tangible Book Value Ann.
285.4285.4
Borrowings Ann.
--
Net Debt Ann.
--
Share Issued Ann.
41.241.2
Number Of Shares End
63.240.5
*All financials are in USD Million and price data in USD

Exascale Labs Holdings Inc ROE, ROCE, book value, and debt-to-equity ratio as of Jun 2026 – 11 year history

  • NEUTRAL

    Book Value Per Share Exascale Labs Holdings Inc Book Value Per Share is $-0 which is growth of 0% YoY.

  • NEUTRAL

    ROE Exascale Labs Holdings Inc ROE is 0% which is growth of 0% YoY.

Exascale Labs Holdings Inc. - Ordinary Shares - Class A, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Dec '25
RoA Ann. %
--
ROE Ann. %
--
ROIC %
--
OPM Ann. %
-32.39%-
Inventory Turnover Ratio Ann.
--
Asset Turnover Ann. %
--
Working Capital Turnover Ann.
--
Quick Ratio Ann.
--
Current Ratio Ann.
--
Interest Coverage Ratio Ann.
--
LT Debt To Equity Ann.
--
*All financials are in USD Million and price data in USD

Exascale Labs Holdings Inc cash flow: net, operating, investing, and financing flows as of Jun 2026 – 11 year history

  • NEUTRAL

    Cash From Operating Activity Exascale Labs Holdings Inc Jun-2026 Cash From Operating Activity is $-3 Million which is growth of 0% YoY.

  • NEUTRAL

    Net Cash Flow Exascale Labs Holdings Inc Jun-2026 Net Cash Flow is $-2 Million which is growth of 0% YoY.

Exascale Labs Holdings Inc. - Ordinary Shares - Class A, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Dec '25
-2.8-
1.4-
-0.2-
Cash Plus Cash Eqv. End Of Year Ann.
2.7-
Net Increase In Cash Plus Cash Eqv.s Ann.
-1.5-
Cash Plus Cash Eqv. Begin Of Year Ann.
4.2-
Income Tax Paid Supplemental Data Ann.
-
Interest Paid Supplemental Data Ann.
-
Capex Ann.
--
Issuance Of Capital Stock Ann.
--
Issuance Of Debt Ann.
--
Repayment Of Debt Ann.
--
Repurchase Of Capital Stock Ann.
--
Free Cash Flow Ann.
-2.8-
*All financials are in USD Million and price data in USD